1454P Optimizing ipilimumab in RCC: Results from SAKK 07/17 (CM-980) nivolumab (N) + ipilimumab (Ipi) in mRCC
| Autor: | Stenner-Liewen, F., Cathomas, R., Rothermundt, C.A., Beyer, J., Mach, N., Zihler, D., Erdmann, A.A., Kueng, M., Dietrich, D., Glaus Garzon, J., Lorch, A., Berthold, D.R., Läubli, H. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1209-S1209 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|